GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Other Current Assets

Tissue Regenix Group (LSE:TRX) Other Current Assets : £0.32 Mil (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Other Current Assets?

Tissue Regenix Group's other current assets for the quarter that ended in Dec. 2023 was £0.32 Mil.

Tissue Regenix Group's quarterly other current assets declined from Dec. 2022 (£0.35 Mil) to Jun. 2023 (£0.11 Mil) but then increased from Jun. 2023 (£0.11 Mil) to Dec. 2023 (£0.32Mil).

Tissue Regenix Group's annual other current assets declined from Dec. 2021 (£0.46 Mil) to Dec. 2022 (£0.35 Mil) declined from Dec. 2022 (£0.35 Mil) to Dec. 2023 (£0.32 Mil).


Tissue Regenix Group Other Current Assets Historical Data

The historical data trend for Tissue Regenix Group's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Other Current Assets Chart

Tissue Regenix Group Annual Data
Trend Jan14 Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.04 0.83 0.46 0.35 0.32

Tissue Regenix Group Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.24 0.35 0.11 0.32

Tissue Regenix Group Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.


Tissue Regenix Group Other Current Assets Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Other Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Tissue Regenix Group (LSE:TRX) Business Description

Traded in Other Exchanges
Address
Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.

Tissue Regenix Group (LSE:TRX) Headlines

From GuruFocus

TanGold Announces Board and Management Change

By GlobeNewswire GlobeNewswire 01-21-2021

Tanzanian Gold Corporation Announces Public Offering of Common Shares

By GlobeNewswire GlobeNewswire 12-16-2019

Tanzanian Royalty Reports Annual Meeting Voting Results

By GlobeNewswire GlobeNewswire 03-23-2019

Doubling of Gold Mineral Resources Confirmed

By GlobeNewswire GlobeNewswire 06-23-2020

Tanzanian Royalty Announces the Sale of Common Shares of $885,734

By GlobeNewswire GlobeNewswire 01-13-2019

Tanzanian Gold Reports Annual Meeting Voting Results

By GlobeNewswire GlobeNewswire 02-28-2020

Tanzanian Gold Clarifies Disclosure

By GlobeNewswire GlobeNewswire 02-21-2020